Pulse hypertension: a new component of the metabolic syndrome in elderly women?
A Mazza1, S Zamboni, V Tikhonoff
1Department of Internal Medicine, General Hospital Rovigo, Rovigo, Italy.
Insights
Metabolic syndrome (MS) predicts coronary heart disease (CHD) mortality in elderly women with untreated hypertension but not treated hypertension. Pulse pressure is the most predictive blood pressure value in treated women.
Area of Science:
- Cardiology
- Gerontology
- Metabolic Diseases
Background:
- Arterial hypertension (HT) classification for metabolic syndrome (MS) lacks consensus due to varying blood pressure (BP) cutoffs.
- Understanding the relationship between HT, MS, and coronary heart disease (CHD) mortality is crucial for population health.
Purpose of the Study:
- To evaluate which arterial hypertension (HT) categorization best defines metabolic syndrome (MS) in relation to coronary heart disease (CHD) mortality at a population level.
- To assess gender-specific risks of CHD mortality associated with different MS definitions in older adults.
Main Methods:
- A 12-year follow-up study of 3257 subjects aged 65 years and older.
- Metabolic syndrome (MS) defined using National Education Cholesterol Program criteria with three HT categories: MS-1 (SBP ≥130 and DBP ≥85 mmHg), MS-2 (SBP ≥130 or DBP ≥85 mmHg), and MS-3 (PP ≥75 mmHg in men, ≥80 mmHg in women).
- Gender-specific adjusted hazard ratios (HR) for CHD mortality derived from Cox analysis, considering antihypertensive treatment status.
Main Results:
- In women with untreated MS, CHD mortality risk was significantly higher across all HT categorizations (MS-1: HR 1.73, MS-2: HR 1.75, MS-3: HR 2.39).
- In women with treated MS, only the MS-3 definition (pulse pressure ≥80 mmHg) showed a significantly increased risk of CHD mortality (HR 1.92).
- Metabolic syndrome (MS) did not predict CHD mortality in men.
Conclusions:
- Metabolic syndrome (MS) predicts coronary heart disease (CHD) mortality in elderly women with untreated hypertension.
- For elderly women with treated hypertension, pulse pressure is the most predictive indicator of CHD mortality within the context of MS.
- Current HT classifications for MS require refinement, particularly for predicting cardiovascular outcomes in older populations.
Abstract:
The classification of arterial hypertension (HT) to define metabolic syndrome (MS) is unclear in that different cutoffs of blood pressure (BP) have been proposed. We evaluated the categorization of HT most qualified to define MS in relationship with coronary heart disease (CHD) mortality at a population level. A total of 3257 subjects aged > or =65 years were followed up for 12 years. MS was defined according to the criteria of the National Education Cholesterol Program using three different categories of HT: MS-1 (systolic blood pressure (SBP) > or =130 and diastolic blood pressure (DBP) > or =85 mm Hg), MS-2 (SBP > or =130 or DBP > or =85 mm Hg) and MS-3 (pulse pressure (PP) > or =75 mm Hg in men and > or =80 mm Hg in women). Gender-specific adjusted hazard ratio (HR) with 95% confidence intervals (CI) for CHD mortality was derived from Cox analysis in the three MS groups, both including and excluding antihypertensive treatment. In women with MS untreated for HT, the risk of CHD mortality was always significantly higher than in those without MS, independent of categorization; the HR of MS was 1.73 (CI 1.12-2.67) using MS-1, 1.75 (CI 1.10-2.83) using MS-2 and 2.39 (CI 3.71-1.31) using MS-3. In women with MS treated for HT, the HR of CHD mortality was significantly increased only in the MS-3 group (1.92, CI 1.1-2.88). MS did not predict CHD in men. In conclusion, MS can predict CHD mortality in elderly women with untreated HT but not in those with treated HT; in the latter, PP is the most predictive BP value.
Related Concept Videos
Hypertension II: Pathophysiology
Hypertension I: Introduction
Measurement of Blood Pressure
Hypertension and Regulation of Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies
Factors affecting Blood pressure
Physiological Factors:
